Vitality Watch

Dossier pubmed observational 28-sep-2026
Human cohort, case-control, or epidemiological association

Opportunistic CT-Based Quantification of Myosteatosis: A Potent Universal Imaging Biomarker for Frailty and Mortality.

Key claim: Opportunistic CT-based quantification of myosteatosis is a potent universal imaging biomarker for frailty and mortality.

Abstract

No abstract available.

Why this matters

Opportunistic CT biomarkers matter because they are extracted from scans people already have, so the measurement cost is near zero and the sample is unselected — a different regime than any clock requiring a dedicated blood draw or questionnaire. Framing myosteatosis as a ‘universal’ frailty and mortality marker consolidates a muscle-quality signal that competes with bedside frailty instruments and with ultrasound/MRI muscle readouts on the same construct. The outstanding question remains whether reducing myosteatosis via exercise or weight change tracks mortality reduction, or whether CT attenuation is only a downstream readout of unmeasured systemic illness.

Source

Link

Briefing card

Opportunistic CT-Based Quantification of Myosteatosis: A Potent Universal Imaging Biomarker for Frailty and Mortality.
Stage: observational · pubmed · 28-sep-2026

If you've had a CT scan for any reason, the same images could in principle be re-analyzed to estimate your muscle fat infiltration as a frailty and mortality risk marker.

Opportunistic CT-based quantification of myosteatosis is a potent universal imaging biomarker for frailty and mortality.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1161/CIRCIMAGING.126.020488

build build 880 · 2bcef25 · 2026-11-18